ALCAR — Carmat SA Share Price
- €30.56m
- €77.64m
- €2.80m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 5.53 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -124.44% | ||
Return on Equity | n/a | ||
Operating Margin | -938.27% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | €m | n/a | n/a | 2.23 | 0.34 | 2.8 | 7.01 | 14.28 | n/a |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Carmat SA, formerly known as Carmat SAS is a France-based company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. It specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.
Directors
- Jean-Pierre Garnier CHM (73)
- Stephane Piat CEO (50)
- Pascale d'Arbonneau CFO
- Eric Richez DSL
- Francesco Arecchi OTH
- Raouia Bouyanzer OTH
- Thierry Dupoux OTH
- Alexandre Eleonore OTH
- Marc Grimme OTH
- Petrus Jansen OTH
- Christian Latremouille OTH
- Ivo Simundic OTH
- Karl Hennessee DRC (47)
- Philippe Pouletty DRC (64)
- Pierre Bastid IND (67)
- Henri Lachmann IND (83)
- Jean-Luc Lemercier IND (64)
- Antonino Ligresti IND (84)
- Michael Mack IND (74)
- Andre Muller IND (58)
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- June 25th, 2008
- Public Since
- July 7th, 2010
- No. of Employees
- 162
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Euronext - Paris
- Shares in Issue
- 35,129,560

- Address
- 36, avenue de l'Europe, VELIZY VILLACOUBLAY, 78140
- Web
- https://www.carmatsa.com/
- Phone
- +33 139456450
- Contact
- Pascale D'Arbonneau
- Auditors
- PricewaterhouseCoopers
Upcoming Events for ALCAR
Carmat SA Annual Shareholders Meeting
Carmat SA Annual Shareholders Meeting
Half Year 2025 Carmat SA Earnings Release
Similar to ALCAR
AbL Diagnostics SA
Euronext - Paris
Affluent Medical SAS
Euronext - Paris
Amplitude Surgical SA
Euronext - Paris
Aton SA
Euronext - Paris
Biomerieux SA
Euronext - Paris
FAQ
As of Today at 19:47 UTC, shares in Carmat SA are trading at €0.87. This share price information is delayed by 15 minutes.
Shares in Carmat SA last closed at €0.87 and the price had moved by -73.11% over the past 365 days. In terms of relative price strength the Carmat SA share price has underperformed the FTSE Global All Cap Index by -73.78% over the past year.
The overall consensus recommendation for Carmat SA is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreCarmat SA does not currently pay a dividend.
Carmat SA does not currently pay a dividend.
Carmat SA does not currently pay a dividend.
To buy shares in Carmat SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €0.87, shares in Carmat SA had a market capitalisation of €30.56m.
Here are the trading details for Carmat SA:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: ALCAR
Based on an overall assessment of its quality, value and momentum Carmat SA is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Carmat SA is €3.60. That is 313.79% above the last closing price of €0.87.
Analysts covering Carmat SA currently have a consensus Earnings Per Share (EPS) forecast of -€1.21 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Carmat SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -40.08%.
As of the last closing price of €0.87, shares in Carmat SA were trading -38.88% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Carmat SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €0.87.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Carmat SA's management team is headed by:
- Jean-Pierre Garnier - CHM
- Stephane Piat - CEO
- Pascale d'Arbonneau - CFO
- Eric Richez - DSL
- Francesco Arecchi - OTH
- Raouia Bouyanzer - OTH
- Thierry Dupoux - OTH
- Alexandre Eleonore - OTH
- Marc Grimme - OTH
- Petrus Jansen - OTH
- Christian Latremouille - OTH
- Ivo Simundic - OTH
- Karl Hennessee - DRC
- Philippe Pouletty - DRC
- Pierre Bastid - IND
- Henri Lachmann - IND
- Jean-Luc Lemercier - IND
- Antonino Ligresti - IND
- Michael Mack - IND
- Andre Muller - IND